NCT03812562View on ClinicalTrials.gov

Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection

EARLY_PHASE1TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

February 7, 2019

Primary Completion Date

October 19, 2023

Study Completion Date

October 19, 2023

Conditions

Hepatocellular Carcinoma

Interventions

BIOLOGICAL

Nivolumab

Given IV

RADIATION

Yttrium Y 90 Glass Microspheres

Given IV

Trial Locations (1)

60611

Northwestern University, Chicago

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER